PharmaEssentia Corporation (LUX: 261280523)
Luxembourg
· Delayed Price · Currency is EUR · Price in USD18.20
-0.90 (-4.71%)
At close: Nov 15, 2024
PharmaEssentia Cash Flow Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Net Income | 1,846 | -623.84 | -1,375 | -2,811 | -1,948 | -842.99 | Upgrade
|
| Depreciation & Amortization | 346.88 | 250.58 | 225.38 | 226 | 174.03 | 136.77 | Upgrade
|
| Other Amortization | 28.47 | 18.18 | 2.54 | 1.09 | 0.76 | 0.67 | Upgrade
|
| Loss (Gain) From Sale of Assets | 0.34 | - | 0.1 | 0.07 | -0.02 | -0.14 | Upgrade
|
| Stock-Based Compensation | 202.91 | 710.21 | 216.21 | 501.52 | 53.76 | 132.81 | Upgrade
|
| Other Operating Activities | -58.71 | -383.62 | -464.93 | 11.18 | -0.33 | 8.88 | Upgrade
|
| Change in Accounts Receivable | -755.14 | -513.66 | -332.6 | -15.45 | 62.49 | -176.36 | Upgrade
|
| Change in Inventory | 105.74 | -356.61 | -240.66 | -466.53 | -137.52 | -221.89 | Upgrade
|
| Change in Accounts Payable | 9.18 | -102.05 | 54.62 | -0.69 | 21.89 | 13.42 | Upgrade
|
| Change in Unearned Revenue | - | - | - | - | -0.07 | 0.07 | Upgrade
|
| Change in Other Net Operating Assets | -188.46 | 295.24 | 408.68 | 91.74 | 317.86 | 3.76 | Upgrade
|
| Operating Cash Flow | 1,537 | -705.56 | -1,505 | -2,462 | -1,455 | -945.02 | Upgrade
|
| Capital Expenditures | -1,100 | -1,286 | -312.03 | -70.33 | -81.16 | -120.73 | Upgrade
|
| Sale of Property, Plant & Equipment | - | - | - | - | 0.23 | 0.14 | Upgrade
|
| Cash Acquisitions | - | - | - | - | -1.73 | - | Upgrade
|
| Sale (Purchase) of Intangibles | -20.87 | -41.65 | -8.72 | -27.54 | -126.36 | -85.54 | Upgrade
|
| Investment in Securities | 25 | -96 | - | -25 | -71.05 | -8.15 | Upgrade
|
| Other Investing Activities | -25.37 | 937.04 | -922.07 | 44.7 | -22.14 | -23.58 | Upgrade
|
| Investing Cash Flow | -1,121 | -486.65 | -1,243 | -78.18 | -302.2 | -237.86 | Upgrade
|
| Short-Term Debt Issued | - | 1 | 973.88 | - | 50 | - | Upgrade
|
| Long-Term Debt Issued | - | - | - | - | 25 | - | Upgrade
|
| Total Debt Issued | 1 | 1 | 973.88 | - | 75 | - | Upgrade
|
| Short-Term Debt Repaid | - | -973.88 | - | -30 | - | -10 | Upgrade
|
| Long-Term Debt Repaid | - | -150.97 | -127.41 | -116.23 | -86.71 | -67.27 | Upgrade
|
| Total Debt Repaid | -259.36 | -1,125 | -127.41 | -146.23 | -86.71 | -77.27 | Upgrade
|
| Net Debt Issued (Repaid) | -258.36 | -1,124 | 846.47 | -146.23 | -11.71 | -77.27 | Upgrade
|
| Issuance of Common Stock | 70.59 | 14,330 | 8,743 | 3,045 | 3,837 | 492.38 | Upgrade
|
| Repurchase of Common Stock | -53.7 | -2,718 | - | -87.5 | -257.24 | -2.01 | Upgrade
|
| Other Financing Activities | -2.6 | -34.56 | -10.26 | -2.41 | -1.42 | -1.61 | Upgrade
|
| Financing Cash Flow | -244.07 | 10,454 | 9,579 | 2,809 | 3,566 | 411.49 | Upgrade
|
| Foreign Exchange Rate Adjustments | 127.07 | 100.16 | 19 | -15.25 | -4.19 | 0.18 | Upgrade
|
| Net Cash Flow | 299.19 | 9,362 | 6,850 | 253.27 | 1,805 | -771.21 | Upgrade
|
| Free Cash Flow | 437.42 | -1,992 | -1,818 | -2,532 | -1,536 | -1,066 | Upgrade
|
| Free Cash Flow Margin | 5.26% | -39.01% | -63.06% | -385.74% | -275.72% | -348.64% | Upgrade
|
| Free Cash Flow Per Share | 1.31 | -6.18 | -6.40 | -9.73 | -6.34 | -4.86 | Upgrade
|
| Cash Interest Paid | 2.6 | 34.56 | 10.26 | 2.41 | 1.42 | 1.61 | Upgrade
|
| Cash Income Tax Paid | 201.5 | 76.87 | 5.68 | -0 | 1.78 | -0.14 | Upgrade
|
| Levered Free Cash Flow | -598.24 | -1,292 | -2,589 | -1,316 | -803.94 | -852.97 | Upgrade
|
| Unlevered Free Cash Flow | -583.9 | -1,263 | -2,577 | -1,310 | -798.78 | -848.27 | Upgrade
|
| Change in Net Working Capital | 705.76 | -281.49 | 1,433 | 176.58 | -252.6 | 381.48 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.